AnorMED Shareholders Vote Overwhelmingly For New Shareholder-Nominated Board
April 21, 2006
Special Committee of AnorMED Board Rejects Compromise Slate of 7 Members
April 12, 2006
Baker refuses previously agreed upon "hybrid" slate - AnorMED Special Committee reviewing alternative proposal
April 9, 2006
AnorMED proposes to negotiate settlement with Baker via neutral third party mediator
April 7, 2006
AnorMED asks BC Supreme Court to order dissidents to correct information in proxy circular
April 6, 2006
AnorMED dissidents fail to justify giving control of AnorMED to Baker Group
April 5, 2006
Angiotech presents positive Adhibit(TM) data at the 19th annual European Congress of Obstetrics and Gynecology
April 7, 2006
Aspreva to Release 2006 First Quarter Results on April 26th
April 12, 2006
New collaborative research to advance early detection of ovarian cancer gets a major boost with $1 million donation to BC Cancer Foundation
April 5, 2006
Special Announcement: CANTEST reorganizes Senior Staff
April 5, 2006
CANTEST acquires specialty analytical laboratory
April 5, 2006
Chemokine Therapeutics achieves critical milestone with the start of a phase Ib/II human clinical trial in cancer
May 2, 2006
Chromos signs agreement with AppTec to manufacture multiple sclerosis drug candidate for toxicology studies and clinical trial using ACE System
April 6, 2006
Leasing Opportunities Available with Discovery Parks
April 20, 2006
EnWave Reorganizes Business and Contracts a Biotechnology Market Assessment Firm
April 13, 2006
Fred Hutchinson Cancer Research Center Deploys GenoLogics’ Proteomics Purposed Software Solution to Accelerate Their Cancer Biomarker Discovery
April 25, 2006
INEX Files Counterclaim Against Protiva Biotherapeutics
May 1, 2006
AnnKatrin Petersen, M.D. Joins MIGENIX as VP Clinical Development
May 1, 2006
Neuromed Named to "Fierce 15" List of Top Emerging Biotech Companies in 2006
April 12, 2006
Neuromed Pharmaceuticals Appoints Former Pfizer Senior Manager to Executive Team
April 10, 2006
Ondine Hires Industry Veteran to Lead US and EU Commercialization Efforts
April 21, 2006
Ondine Biopharma Appoints Michael Richard Crane to its Board of Directors
May 1, 2006
Pacgen Biopharmaceuticals Appoints Christina Yip as Chief Financial Officer
April 20, 2006
Pacgen Biopharmaceuticals Acquires IL Therapeutics Inc.
April 12, 2006
QLT Announces Visudyne(R) Sales for First Quarter of 2006
April 24, 2006
QLT Announces That Court of Appeals Grants Stay of Injunction Against Eligard(R) Sales
April 5, 2006
QLT Announces Co-Development and Licensing Agreement with Retinagenix for Early Stage Ocular Synthetic Retinoid Program
April 5, 2006
Stressgen announces new head of Research & Development
April 18, 2006
Stressgen provides corporate and HspE7 program updates
April 19, 2006
Stressgen announces changes to its Board of Directors
April 6, 2006
Vancouver Island Technology Park welcomes expansion of Aspreva's global Headquarters
May 2, 2006
Welichem Announces Creation of New Controlling Shareholder
April 27, 2006
Xenon Raises US$31 Million in Private Financing - Advancing pipeline into clinical development
April 11, 2006
|
